Screening tests for anal precancer in women with HPV-related gynecological disease
Tests HPV and cell screening to find anal precancer in women with HPV-related disease.
Plain-language title generated from the registry record
Registry title: Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
Key facts
- Where
- Gdynia, PolandSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with an HPV-related gynecological disease that was confirmed under the microscope. Samples must be possible from the gynecological organ and the anal canal.
- Sex
- Women only.
- Disease stage
- An HPV-related gynecological disease (precancer or cancer) confirmed by tissue examination.
Read by machine on 12 November 2026.
Where in Poland
- PCK Marine Hospital in GdyniaGdynia, PolandContact: Michał BrzezińskiTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- PCK Marine Hospital in Gdynia
- Trial code
- NCT06574087
- Record updated
- 23 July 2025
- Original description
The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.Read full original descriptionShow less
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. Moreover, the most appropriate screening test for HSIL(AIN) in this group of patients will be determined. It will be effectuated by performing two kinds of tests: hrHPV test for the 14 most common oncogenic HPV types and the liquid cytology from both the lower genital tract and anal canal with subsequent high resolution anoscopy (HRA) with potential biopsy/excision of suspected lesions and histopathological examination.
Inclusion: HPV related gynecological disease confirmed in histo-pathological examination; the posibility to obtain material from gynecological organ and from anal canal.